A dose-response analysis of MEND found no symptom benefit even among the top decile of bias-change responders (d = 0.11, ns)
[unresolved]
[no evidence]
[quiet]
[stable]
[undecided]
Among the 120 participants whose interpretation bias shifted by more than 1.5 SD, 12-month BDI-II change did not differ from controls. The absence of a responder subgroup argues against the interpretation that the null was driven by dilution from non-engagers.
Accurate
(+0)
Falsifiable
(+0)
Clear
(+0)
Novel
(+0)
Important
(+0)
▸ Score Details
Cited as evidence in 1 claim:
Randomized cognitive-bias modification targeting threat app…
(opposes)
cited by (1)
cited as opposes by:
[+0]
Randomized cognitive-bias modification targeting threat appraisal reduced appraisal bias by 0.62 SD but depression symptoms by only 0.08 SD at 12 months
clinical-psychology
randomized-trials
virtues: Accurate unrated · Falsifiable unrated · Clear unrated · Novel unrated · Important unrated
this claim:
A dose-response analysis of MEND found no symptom benefit even among the top decile of bias-change responders (d = 0.11, ns)
supports (0)
no supporting evidence yet
opposes (0)
no opposing evidence yet
Evidence Supporting (0)
No supporting evidence yet.
Evidence Against (0)
No opposing evidence yet.
Respondeo
Loading responses...
Log in to join the discussion.